<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04790214</url>
  </required_header>
  <id_info>
    <org_study_id>CARECA-CHF</org_study_id>
    <nct_id>NCT04790214</nct_id>
  </id_info>
  <brief_title>Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon</brief_title>
  <acronym>CARECA-CHF</acronym>
  <official_title>Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yaounde Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yaounde Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CARECA-CHF study is a non-randomized, prospective, single-arm study, enrolled ambulatory&#xD;
      patients with stable chronic heart failure [New York Heart Association (NYHA) class II/III].&#xD;
      Patients will be followed-up during a period of 06-08 weeks. The aim of this study is to&#xD;
      assess the effect of a cardiac rehabilitation program on patients with stable chronic heart&#xD;
      failure in Yaoundé, Cameroon.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CARECA-CHF study is a non-randomized, prospective, single-arm study, multicentric study.&#xD;
      Patients with stable chronic heart failure [New York Heart Association (NYHA) class II/III]&#xD;
      will be enrolled ambulatory. The program will take place during a period of 06-08 weeks.&#xD;
&#xD;
      The aim of this study is to assess the effect of a cardiac rehabilitation program on patients&#xD;
      with stable chronic heart failure in a resource-limited country.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients with stable CHF in stage II or III of the New York Heart Association.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of VO2 max</measure>
    <time_frame>8 weeks</time_frame>
    <description>Variation of VO2 max at baseline and the end of the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation in 6-minute walk test (6MWT) distance</measure>
    <time_frame>8 weeks</time_frame>
    <description>Variation in 6MWT in meter distance from the baseline to week 6 or 8. By using pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of duration of exercise and maximum load</measure>
    <time_frame>8 weeks</time_frame>
    <description>variation in duration of exercise and maximum load expressed by watt power</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation in level of anxiety and depression;</measure>
    <time_frame>8 weeks</time_frame>
    <description>Difference in level of anxiety and depression assessed by a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life assessed by the Minnesota Living With Heart Failure Questionnaire (MLWHFQ)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change in quality of life assessed by the Minnesota Living With Heart Failure Questionnaire (MLWHFQ) Minnesota Living With Heart Failure Questionnaire score at Week 8 adjusted for baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of time-domain heart rate variability (HRV) parameters</measure>
    <time_frame>8 weeks</time_frame>
    <description>Variation of time-domain heart rate variability parameters before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of frequency-domain HRV parameters</measure>
    <time_frame>8 weeks</time_frame>
    <description>variation of frequency-domain HRV parameters before and after the intervention. Variation of frequency-domain HRV parameters (HF, LF, LF/HF) before and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of index hypopnea-apnea index</measure>
    <time_frame>8 weeks</time_frame>
    <description>Variation of variation of index hypopnea-apnea after 6-8 weeks of aerobic training.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of sleep quality index</measure>
    <time_frame>8 weeks</time_frame>
    <description>variation of sleep quality index by Pittsburg questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of nocturnal saturation</measure>
    <time_frame>8 weeks</time_frame>
    <description>Variation of nocturnal saturation by oxymeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non adherence</measure>
    <time_frame>8weeks</time_frame>
    <description>evaluation of non adherence by questionnaire at the end of the study</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Heart Failure (CHF)</condition>
  <arm_group>
    <arm_group_label>Stable CHF patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stable CHF patients on stage II/III based on the New York Heart Failure classification</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CHF Patients</intervention_name>
    <description>Cardiac rehabilitation program on CHF patients on 06-08 weeks. Program will include: physical aerobic re-training, therapeutic education on CHF, psychological follow-up, nutritional education</description>
    <arm_group_label>Stable CHF patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with stable chronic heart failure confirmed by a cardiac ultrasound and whose&#xD;
             severity is rated stage II or III of NYHA followed at Yaoundé central hospital and&#xD;
             Yaoundé general hospital;&#xD;
&#xD;
          -  Stable under treatment;&#xD;
&#xD;
          -  Whose cardiac ultrasound is less than six months old;&#xD;
&#xD;
          -  Having given his free and informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Poor adherence to the cardiac rehabilitation program activities;&#xD;
&#xD;
          -  Patients lost insight the program;&#xD;
&#xD;
          -  Withdrawal of informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Nadège N Nganou-Gnindjio, MD, MAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yaounde Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr Chris Nadège Nganou-Gnindjio</name>
      <address>
        <city>Yaoundé</city>
        <zip>BP: 35307 Bastos</zip>
        <country>Cameroon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Cameroon</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yaounde Central Hospital</investigator_affiliation>
    <investigator_full_name>CN NGANOU-GNINDJIO, MD, MSc</investigator_full_name>
    <investigator_title>Dr, Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Cardiac rehabilitation</keyword>
  <keyword>Chronic Heart failure</keyword>
  <keyword>Physical function</keyword>
  <keyword>Cameroon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

